0000912282-25-001056.txt : 20251010 0000912282-25-001056.hdr.sgml : 20251010 20251009180901 ACCESSION NUMBER: 0000912282-25-001056 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251010 DATE AS OF CHANGE: 20251009 EFFECTIVENESS DATE: 20251010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Flora Growth Corp. CENTRAL INDEX KEY: 0001790169 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560423 FILM NUMBER: 251386023 BUSINESS ADDRESS: STREET 1: 3230 W. COMMERCIAL BOULEVARD STREET 2: SUITE 180 CITY: FORT LAUDERDALE STATE: FL ZIP: 33309 BUSINESS PHONE: 416-861-2267 MAIL ADDRESS: STREET 1: 3230 W. COMMERCIAL BOULEVARD STREET 2: SUITE 180 CITY: FORT LAUDERDALE STATE: FL ZIP: 33309 D 1 primary_doc.xml X0708 D LIVE 0001790169 Flora Growth Corp. 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 604-609-0244 ONTARIO, CANADA None None Corporation true Daniel Reis-Faria 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 Director Executive Officer Michael Heinrich 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 Director Executive Officer Dany Vaiman 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 Executive Officer Edward Woo 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 Director Manfred Leventhal 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL FLORIDA 33309 Director Other Decline to Disclose 06b false 2025-09-26 true true true true true Cash warrants exerciseable at $25.19 until September 25, 2030. Prefunded warrants expire when exercised in full. false 0 4233401 3554950 678451 Total amount remaining to be sold represents maximum potential exercise price of warrants. false 11 0 0 0 false Flora Growth Corp. /s/ Dany Vaiman Dany Vaiman CFO 2025-10-09